The relationships between CSF neuropeptide concentrations, hypertension, diabetes and fasting blood cholesterol levels are particularly interesting in view of the metabolic and non-clinical abnormalities, such as alterations in body weight and neuroendocrine functions, which often precede the cognitive decline (Low and Singer, 2008; McGrath et al., 2017). The gene discussed is NPS; the disease is diabetes mellitus.